| 1 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国CSVD诊治共识 [J]. 中华神经科杂志, 2015, 48（10）: 838-844.
|
| 2 |
黄勇华, 赵弘轶. CSVD研究新理念[J], 中国现代神经疾病杂志, 2019, 19(7): 461-465.
|
| 3 |
Pantoni L, Gorelick PB. Cerebralsmallvesseldisease [J]. 2014, Cambridge University Press.
|
| 4 |
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration [J]. Lancet Neurol, 2013, 12(8): 822-838.
|
| 5 |
Cummings JL. Frontal-subcortical circuits and human behavior [J]. J Psychosom Res, 1998, 44(6): 627-628.
|
| 6 |
Vasquez BP, Zakzanis KK. The neuropsychological profile of vascular cognitive impairment not demented: a meta-analysis [J]. J Neuropsychol, 2015, 9(1): 109-136.
|
| 7 |
Ter Telgte A, van Leijsen EMC, Wiegertjes K, et al. Cerebral small vessel disease: from a focal to a global perspective [J]. Nat Rev Neurol, 2018, 14(7): 387-398.
|
| 8 |
Maniega SM, Valdés Hernández MC, Clayden JD, et al. White matter hyperintensities and normal⁃appearing white matter integrity in the aging brain [J]. Neurobiol Aging, 2015, 36(2): 909-918.
|
| 9 |
Tuladhar AM, van Dijk E, Zwiers MP, et al. Structural network connectivity and cognition in cerebral small vessel disease [J]. Hum Brain Mapp, 2016, 37(1): 300-310.
|
| 10 |
Lawrence AJ, Chung AW, Morris RG, et al. Structural network efficiency is associated with cognitive impairment in small-vessel disease [J]. Neurology, 2014, 83(4): 304-311.
|
| 11 |
Fornito A, Zalesky A, Breakspear M. The connectomics of brain disorders [J]. Nat Rev Neurosci, 2015, 16(3): 159-172.
|
| 12 |
Stern Y. Cognitive reserve [J]. Neuropsychologia, 2009, 47(10): 2015-2028.
|
| 13 |
van Leijsen EMC, de Leeuw FE, Tuladhar AM. Disease progression and regression in sporadic small vessel disease: insights from neuroimaging [J]. Clin Sci (Lond), 2017, 131(12): 1191-1206.
|
| 14 |
Schmidt R, Enzinger C, Ropele S, et al. Progression of cerebral white matter lesions: 6⁃year results of the Austrian Stroke Prevention Study [J]. Lancet, 2003, 361(9374): 2046-2048.
|
| 15 |
Van Leijsen EM, Bergkamp MI, Van Uden IW, et al. Cognitive consequences of regression of cerebral small vessel disease [J]. Eur Stroke J, 2019, 4(1): 85-89.
|
| 16 |
Østergaard L, Engedal TS, Moreton F, et al. Cerebral small vessel disease: capillary pathways to stroke and cognitive decline [J]. J Cereb Blood Flow Metab, 2015, 36(2): 302-325.
|
| 17 |
朱以诚. CSVD临床研究中的重要问题[J]. 中国卒中杂志, 2015, 10(12): 996-999.
|
| 18 |
中华医学会老年医学分会老年神经病学组, CSVD认知功能障碍诊疗指南中国撰写专家组. CSVD相关认知功能障碍中国诊疗指南（2019） [J]. 中华老年医学杂志, 2019, 38(4): 345-354.
|
| 19 |
Au R, Piers RJ, Devine S. How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study [J]. Neuropsychology, 2017, 31(8): 846-861.
|
| 20 |
Cha DS, Carmona NE, Rodrigues NB, et al. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder [J]. J Affect Disord, 2018, 238: 228-232.
|
| 21 |
Wei W, Zhào H, Liu Y, et al. Traditional trail making test modified into brand-new assessment tools: digital and walking trail making test [J]. J Vis Exp, 2019, 23; 153
|
| 22 |
Hao X, Huang Y, Li X, et al. Structural and functional neural correlates of spatial navigation: a combined voxel-based morphometry and functional connectivity study [J]. Brain Behav, 2016, 6(12): e00572.
|
| 23 |
European Medicines Agency. Clinical Trial Regulation; 2017. Available at:
URL
|
| 24 |
Michael G, Joan A, Carrillo MC, et al. Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials [J]. Alzheimers Dement(N Y), 2018, 24(4): 234-242.
|
| 25 |
Shaaban CE, Aizenstein HJ, Jorgensen DR, et al. In vivo imaging of venous side cerebral small-vessel disease in older adults: an MRI method at 7T [J]. AJNR Am J Neuroradiol, 2017, 38(10): 1923-1928.
|
| 26 |
Moody DM, Brown WR, Challa VR, et al. Periventricular venous collagenosis: association with leukoaraiosis[J]. Radiology, 1995, 194(2): 469-476.
|
| 27 |
De Guio F, Jouvent E, Biessels GJ, et al. Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease [J]. J Cereb Blood Flow Metab, 2016, 36(8): 1319-1337.
|
| 28 |
石文磊, 韩红梅, 王国强, 等. CSVD的遗传学研究进展 [J]. 中华神经科杂志, 2017, 16(2): 204-208.
|
| 29 |
Choi JC. Genetics of cerebral small vessel disease [J]. J Stroke, 2015, 17(1): 7-16.
|
| 30 |
Giau VV, Bagyinszky E, Youn YC, et al. Genetic factors of cerebral small vessel disease and their potential clinical outcome [J]. Int J Mol Sci, 2019, 20(17). pii: E4298.
|
| 31 |
ten Dijke P, Arthur HM. Extracellular control of TGF beta signalling in vascular development and disease [J]. Nat Rev Mol Cell Biol, 2007, 8(11): 857-869.
|
| 32 |
Biffi A, Anderson CD, Jagiella JM, et al. APOE Genotype Predicts Extent of Bleeding and Outcome in Lobar Intracerebral Hemorrhage [J]. Lancet Neurology, 2011, 10(8): 702-709.
|
| 33 |
Bersano A, Debette S, Zanier ER, et al. The genetics of small-vessel disease [J]. Curr Med Chem, 2012, 19(24): 4124-4141.
|